Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides. - Wikidata - awgldk - TriplyDB

Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides.

Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides.

http://www.wikidata.org/entity/Q40110178

about

An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential Structural and functional coordination of DNA and histone methylation Beyond hypomethylating agents failure in patients with myelodysplastic syndromes Epigenetics advancing personalized nanomedicine in cancer therapy Predicting response to epigenetic therapy Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9a Advancements in the delivery of epigenetic drugs Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study Demethylating Agents in the Treatment of Cancer Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells.S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth.A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potency Current limitations and future opportunities for epigenetic therapies.Pathogenetic mechanisms in gastric cancer.Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.Dynamics of histone lysine methylation: structures of methyl writers and erasers The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer.Augmenting antitumor immune responses with epigenetic modifying agents.Development of an oral form of azacytidine: 2'3'5'triacetyl-5-azacytidine.Lysine methyltransferase G9a is not required for DNMT3A/3B anchoring to methylated nucleosomes and maintenance of DNA methylation in somatic cells SGI-110: DNA Methyltransferase Inhibitor Oncolytic Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.Targeting epigenetic regulations in cancer The relationship between promoter methylation of p16 gene and bladder cancer risk: a meta-analysis.Digging deep into "dirty" drugs - modulation of the methylation machinery.Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management.DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines Targeting DNA methylation.Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA.Chemical decomposition of 5-aza-2'-deoxycytidine (Decitabine): kinetic analyses and identification of products by NMR, HPLC, and mass spectrometry.Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites?DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.Epigenetic modifications as therapeutic targets.

P2860

Q24622700-50C5418E-2C5C-4383-90FA-A0FFD3247332 Q26782613-2A2F78FD-6BEA-44F5-8AB1-8F40BDDC29EC Q26825534-C7AB54B8-E49A-4EEA-8D53-A31093C8B957 Q26827079-C6F621BA-0CBB-416B-B877-656FA17AD337 Q27010637-228ACE7E-3283-4CE0-8942-7F145983F3A6 Q27027751-A2F03B3E-965D-4F03-ABEF-2507E7C79F9A Q27653816-9F9B1E23-E509-4200-A9A8-C373615DB62C Q27675594-9E11086A-4FF2-4488-985B-5B8C0012673E Q28088478-F0D740DA-A709-4A90-B068-42048E595C16 Q33425338-42B6AE67-8A4E-4075-AE2F-11A7FCC054CB Q33678040-34275E4C-73D8-4487-8A28-64D6C5635689 Q33798412-7F4BDFD8-F37D-4B8F-B27D-742DFABD88AD Q33843593-B27ADDDD-3F82-4302-A97E-A26BA0CEF8AB Q33901844-0C38CCE4-7664-4A1F-8433-FF4F0560F017 Q33980682-FD4206C3-32F0-4CA0-98BC-5CDCCCA0B891 Q34015916-7C2CD266-B41A-4DC9-BA87-65C4FF2DBEB5 Q34195077-A8A4D300-AB54-4382-90F0-1A4B5DE39420 Q34326627-2D850961-65BA-4B1D-8BDC-65496DFBB762 Q34606426-154481F1-71A1-4989-9FA8-2300FAADBDC4 Q34620820-5F96995E-24C0-414E-8AB6-32439CBC294D Q34717933-DF987788-DB29-4CAB-A52E-106FD87DD5D5 Q35048054-1CF80AE9-AF2B-4293-8E14-07012F4B98D4 Q35687461-9801623A-F7C6-460F-89B6-1E06745E2866 Q35799453-D486DEDB-2F45-4834-BECD-E829779940D6 Q35854709-F43DDA1A-8522-41FE-8E6C-AFBCA5969648 Q36067023-B5180E14-224C-4730-B0F1-29DF3B4A7E56 Q36214731-691A9F87-2F03-413B-8B76-043934A34BA2 Q36398751-0DDE3847-E54E-40EA-90B0-8EF67C539C54 Q36492827-8535624C-B027-44CE-A287-589E26213AB1 Q36523796-344BA331-2581-4B6B-8050-F99F9BECA8D6 Q36548335-D86E2BE4-AABB-4ACA-9C47-B7F0FE677999 Q36738463-C888473B-BAB1-4A0E-A311-3A82DE87349C Q37055333-697C94EB-E1DA-40DF-9DFE-86AFF3BE6639 Q37066258-1CBE04AA-D265-498F-BFAC-A852ABCF4AF9 Q37320354-C5056031-4693-40B3-A085-8A81F7B01512 Q37355969-AD64C5B6-66AE-41C0-ACF7-234E44C55C76 Q37700645-283DB517-D73E-4D36-B1B9-51F3B14B3D36 Q37701947-1392D4F8-764E-409F-9D66-5A7C5E687BFC Q37729405-82B9EBD9-A14F-4C2D-A649-D820C2F9BB41 Q37800011-0A66F161-4D11-46BA-A8BD-7740A79DEA9B

P2860

Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides.

http://www.wikidata.org/entity/Q40110178

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides.

@en

type

label

Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides.

@en

prefLabel

Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides.

@en

P1433

Q40110178-0E445F1B-3E27-486F-9BC8-72F9FD11D053

P1476

Q40110178-57C5C8A0-1932-4B55-B9FE-83076115BA34

P2093

Q40110178-487A2578-2129-403D-8B2C-355CA446CAA4

Q40110178-505EF8E9-24E9-4FCA-8794-49BFB5B259A2

Q40110178-8AF7991C-2CC0-4839-8987-F7D01E8BDB78

Q40110178-B6B1F007-3BC1-49D2-9DBD-C5B3C475E3F9

Q40110178-B95C36FF-8866-4841-B229-C7FCAF54C00A

Q40110178-C5BE564E-32D3-47C4-A484-335A3B86A1B6

Q40110178-CE0E2CF0-66B9-4C99-B970-0C059520E82C

Q40110178-E6D8B78A-163E-4830-BD23-FF7743F6FB0F

P304

Q40110178-579242FC-8714-4A8A-9EE0-E69675501271

P31

Q40110178-6CE9F434-1EC4-4F8C-B040-699625C32488

P356

Q40110178-B911998E-3B6F-4D37-8CF8-5B64AC0D7A8A

P407

Q40110178-CA60677D-1CCB-4A3C-80C2-B71B303EDD7B

P433

Q40110178-6AE5F110-679B-44E7-A166-6C137F61E6A8

P478

Q40110178-3B2799BF-339C-471F-AD5D-C1EA912A9FA4

P577

Q40110178-A16CF615-F7EB-4788-9AEE-95E2F0751D81

P5875

Q40110178-605120D0-C0ED-43AF-92D8-71DDBDE8B4CF

P698

Q40110178-D25B84EC-FEE2-4477-A792-F4843194B3DC

P356

0008-5472.CAN-07-0251

P1433

Cancer Research

P1476

Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides.

@en

P2093

Christine B Yoo

http://www.w3.org/2001/XMLSchema#string

Chunlin Tang

http://www.w3.org/2001/XMLSchema#string

Gangning Liang

http://www.w3.org/2001/XMLSchema#string

Gerda Egger

http://www.w3.org/2001/XMLSchema#string

Pasit Phiasivongsa

http://www.w3.org/2001/XMLSchema#string

Peter A Jones

http://www.w3.org/2001/XMLSchema#string

Sanjeev Redkar

http://www.w3.org/2001/XMLSchema#string

Shinwu Jeong

http://www.w3.org/2001/XMLSchema#string

P304

6400-6408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-07-0251

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6220606

http://www.w3.org/2001/XMLSchema#string

P698

17616700

http://www.w3.org/2001/XMLSchema#string